These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
123 related items for PubMed ID: 15632911
21. Intensive chemoradiotherapy as a primary treatment for organ preservation in patients with advanced cancer of the head and neck: efficacy, toxic effects, and limitations. Hanna E, Alexiou M, Morgan J, Badley J, Maddox AM, Penagaricano J, Fan CY, Breau R, Suen J. Arch Otolaryngol Head Neck Surg; 2004 Jul; 130(7):861-7. PubMed ID: 15262764 [Abstract] [Full Text] [Related]
22. Head and neck squamous cell carcinoma and metachronous second primaries. Haremza C, Baert M, Pascual C, Biet-Hornstein A, Page C. Eur Ann Otorhinolaryngol Head Neck Dis; 2019 Oct; 136(5):367-372. PubMed ID: 31208879 [Abstract] [Full Text] [Related]
23. Use of external beam radiotherapy is associated with reduced incidence of second primary head and neck cancer: a SEER database analysis. Rusthoven K, Chen C, Raben D, Kavanagh B. Int J Radiat Oncol Biol Phys; 2008 May 01; 71(1):192-8. PubMed ID: 18078720 [Abstract] [Full Text] [Related]
29. Cervical lymph node metastases from occult squamous cell carcinoma: analysis of 82 cases. Boscolo-Rizzo P, Da Mosto MC, Gava A, Marchiori C. ORL J Otorhinolaryngol Relat Spec; 2006 May 01; 68(4):189-94. PubMed ID: 16479145 [Abstract] [Full Text] [Related]
30. Mutagen sensitivity as a biomarker for second primary tumors after head and neck squamous cell carcinoma. Cloos J, Leemans CR, van der Sterre ML, Kuik DJ, Snow GB, Braakhuis BJ. Cancer Epidemiol Biomarkers Prev; 2000 Jul 01; 9(7):713-7. PubMed ID: 10919742 [Abstract] [Full Text] [Related]
31. Racial differences in stage and survival in head and neck squamous cell carcinoma. Nichols AC, Bhattacharyya N. Laryngoscope; 2007 May 01; 117(5):770-5. PubMed ID: 17473666 [Abstract] [Full Text] [Related]
33. An assessment of risk factors for the development of a second primary malignancy in the head and neck. Bhattacharyya N. Ear Nose Throat J; 2006 Feb 01; 85(2):121-5. PubMed ID: 16579204 [Abstract] [Full Text] [Related]
36. Staging and survival analysis for nonsquamous cell carcinomas of the larynx. Lin HW, Bhattacharyya N. Laryngoscope; 2008 Jun 01; 118(6):1003-13. PubMed ID: 18388773 [Abstract] [Full Text] [Related]
37. The influence of lymph node metastasis in the treatment of squamous cell carcinoma of the oral cavity, oropharynx, larynx, and hypopharynx: N0 versus N+. Layland MK, Sessions DG, Lenox J. Laryngoscope; 2005 Apr 01; 115(4):629-39. PubMed ID: 15805872 [Abstract] [Full Text] [Related]
38. Efficacy and toxicity of reirradiation using intensity-modulated radiotherapy for recurrent or second primary head and neck cancer. Sher DJ, Haddad RI, Norris CM, Posner MR, Wirth LJ, Goguen LA, Annino D, Balboni T, Allen A, Tishler RB. Cancer; 2010 Oct 15; 116(20):4761-8. PubMed ID: 20572036 [Abstract] [Full Text] [Related]
39. Matched-pair analysis of survival of never smokers and ever smokers with squamous cell carcinoma of the head and neck. Pytynia KB, Grant JR, Etzel CJ, Roberts DB, Wei Q, Sturgis EM. J Clin Oncol; 2004 Oct 01; 22(19):3981-8. PubMed ID: 15459221 [Abstract] [Full Text] [Related]
40. Synchronous and metachronous head and neck carcinomas. Schwartz LH, Ozsahin M, Zhang GN, Touboul E, De Vataire F, Andolenko P, Lacau-Saint-Guily J, Laugier A, Schlienger M. Cancer; 1994 Oct 01; 74(7):1933-8. PubMed ID: 8082099 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]